Effective third-party due diligence in the age of AI

In today’s rapidly evolving regulatory and technological environment, life sciences companies are under heightened pressure to strengthen their third-party due diligence processes. With the rise of artificial intelligence (AI), organizations face new opportunities to improve efficiency and accuracy, while also encountering new risks and complexities. This discussion between Baker Tilly and TDI will examine how compliance leaders can balance cutting-edge AI solutions with traditional human-sourced diligence to ensure reliable, defensible results. 

We will explore key considerations for designing cost-effective due diligence programs, strategies for overcoming compliance challenges unique to the life sciences industry, and practical approaches for managing high-risk third parties across global supply chains. Attendees will gain actionable insights to enhance their compliance frameworks, strengthen vendor oversight, and drive more informed, risk-based decisions. 

Who should attend 

• Compliance officers, risk managers, procurement professionals, legal advisors, and executives within the life sciences sector who are responsible for third-party risk management and regulatory compliance. 

Presenters 

• Mario Prohasky, Director, Baker Tilly 
• David Fisher, President, TDI 

Learning objectives 

• Building effective due diligence programs and best practices for screening third parties. 
• Balancing the use of AI-driven tools with human-sourced research for reliable outcomes. 
• Addressing the unique challenges of managing high-risk third parties across the life sciences supply chain.